Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05669482
What this trial is testing

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Who this might be right for
KRAS Activating MutationMetastatic CancerPancreas Cancer+2 more
Verastem, Inc. 40
Post-approval studies (Phase 4)WithdrawnNCT03891979
What this trial is testing

Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT06381154
What this trial is testing

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more
Mayo Clinic 24
Very early researchStudy completedNCT02295956
What this trial is testing

Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT06188702
What this trial is testing

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

Who this might be right for
MTAP-deleted Solid Tumors
Servier Bio-Innovation LLC 60
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Large-scale testing (Phase 3)Study completedNCT00003029
What this trial is testing

Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 200
Testing effectiveness (Phase 2)Study completedNCT05031494
What this trial is testing

Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers

Who this might be right for
MelanomaPancreatic Ductal Adenocarcinoma
Eucure (Beijing) Biopharma Co., Ltd 40
Large-scale testing (Phase 3)Looking for participantsNCT06782412
What this trial is testing

Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

Who this might be right for
Oesophageal CancerGastric CancerPancreatic Ductal Adenocarcinoma+3 more
KU Leuven 109
Testing effectiveness (Phase 2)Study completedNCT00499265
What this trial is testing

Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Heidelberg Pharma AG 95
Not applicableNot Yet RecruitingNCT06399172
What this trial is testing

OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
OncoSil Medical Limited 50
Testing effectiveness (Phase 2)UnknownNCT05042128
What this trial is testing

The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 158
Early research (Phase 1)UnknownNCT04612530
What this trial is testing

PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic Cancer
Amsterdam UMC, location VUmc 18
Testing effectiveness (Phase 2)Study completedNCT02178709
What this trial is testing

A Phase II Study of Neoadjuvant FOLFIRINOX

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma
Indiana University 48
Early research (Phase 1)Study completedNCT02237157
What this trial is testing

A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
RenovoRx 20
Large-scale testing (Phase 3)Study completedNCT02184195
What this trial is testing

Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Who this might be right for
Germline BRCA1/2 Mutations andMetastatic Adenocarcinoma of the Pancreas
AstraZeneca 154
Testing effectiveness (Phase 2)Study completedNCT02005419
What this trial is testing

Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

Who this might be right for
Stage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more
Xian-Jun Yu 300
Testing effectiveness (Phase 2)Looking for participantsNCT07629609
What this trial is testing

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Who this might be right for
Pancreatic Cancer, AdultGastroesophageal Cancer (GC)
Barbara Malene Fischer 90
Early research (Phase 1)Study completedNCT01487785
What this trial is testing

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Ended earlyNCT03723915
What this trial is testing

Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8
Northwestern University 17
Next Page